Holen Sie sich die Stockscreener-App
1.47
5.00%
0.07
Handel nachbörslich:
1.51
0.04
+2.72%
Finanzdaten der Regulus Therapeutics Inc-Aktie (RGLS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
6.34%
8.826
|
8.30 | 8.125 | 7.315 | 7.369 |
| Interest Income/Expense |
28.95%
0.081
|
0.114 | 0.137 | 0.168 | 0.185 |
| Operating Income/Loss |
6.34%
-8.826
|
-8.30 | -8.125 | -7.315 | -7.369 |
| Income/Loss From Continuing Operations Before Tax |
5.06%
-8.469
|
-8.061 | -7.824 | -7.012 | -7.139 |
| Income/Loss From Continuing Operations After Tax |
5.06%
-8.469
|
-8.061 | -7.824 | -7.013 | -7.139 |
|
Net Income/Loss
|
5.06%
-8.469
|
-8.061 | -7.824 | -7.013 | -7.139 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
6,661%
28.75
|
0.4252 | 19.63 | 19.10 | 16.84 |
| Diluted Average Shares |
6,661%
28.75
|
0.4252 | 19.63 | 19.10 | 16.84 |
| Basic Earnings Per Share |
110.47%
-0.29
|
2.77 | -0.40 | -0.37 | -0.42 |
| Diluted Earnings Per Share |
110.47%
-0.29
|
2.77 | -0.40 | -0.37 | -0.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.89%
2.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):